BioSyntech, Inc.
OTC: BSYI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Amine Selmani
- Headquarters
- Laval, Canada
- IPO year
- 2000
- Market cap
- $229.0K
- Website
- https://biosyntech.com/
Loading BSYI…
Loading profile data…Frequently asked questions about BSYI
What does BioSyntech, Inc. (BSYI) do?
BioSyntech, Inc. is dedicated to developing advanced biotherapeutic thermogels aimed at both repairing tissues and delivering therapeutic compounds. The company's key product pipeline features BST-CarGel, a biodegradable gel designed for cartilage repair; BST-InPod, intended for alleviating heel discomfort; BST-DermOn, for managing and healing c...
Where does BSYI trade?
BioSyntech, Inc. (BSYI) trades on the Other OTC.
What sector is BSYI in?
BioSyntech, Inc. (BSYI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of BioSyntech, Inc.?
Amine Selmani is the chief executive officer of BioSyntech, Inc. (BSYI).
Where is BioSyntech, Inc. headquartered?
BioSyntech, Inc. is headquartered in Canada.
Does BSYI pay a dividend?
BioSyntech, Inc. (BSYI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BSYI go public?
BioSyntech, Inc. (BSYI) completed its initial public offering in 2000.